CME-Directory

Description: Oncology Practice Reviews *Part of a PER conference series [ View Series Overview ] JW Marriott Hotel Los Angeles at L.A. LIVE Los Angeles, CA March 26-27, 2010 Conference Overview CME-Certified Symposium This activity is presented by Physicians’ Education Resource in conjunction with the Keck School of Medicine of the University of Southern California. Oncology Practice Reviews is a 2-day symposium designed to educate community physicians on the state-of-the-art clinical management of a wide variety of solid and hematologic malignancies. Lectures will highlight cutting-edge information and emerging treatment strategies for specific tumor types, including breast cancer, genitourinary malignancies, lymphoma, gastrointestinal malignancies, lung cancer, multiple myeloma, myelodysplastic syndromes, leukemia, and chronic lymphocytic leukemia, in addition to other special topics unique to each meeting location. To enhance learning, participants will be engaged in solving “real-world” problems through practical, interactive, case-based presentations. * Industry-led lectures and exhibits will be conducted as optional learning opportunities in conjunction with this event. These optional activities are not certified for CME credit and are not planned or sanctioned by PER. Product and Research & Development Theaters will provide promotional product-specific information on available agents and products in development, respectively. Target Audience This educational program is directed toward medical oncologists and hematologists practicing in the community or academic setting who are interested in recent advances in the treatment of solid tumors and hematologic malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to attend. Learning Objectives At the conclusion of this symposium, you should be able to: • Assess the efficacy and safety of targeted agents in the management of patients with solid tumors and hematologic malignancies • Identify results of recent clinical trials that are currently applicable to the management of patients with solid tumors and hematologic malignancies Continuing Education Information Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Physicians’ Education Resource designates this educational activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME. Registered Nurses: The California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ toward license renewal. On the BRN license renewal form, report the number of hours you attended (up to 12.25 hours of credit) and fill in “CME Category 1” for the provider number. California AB 1195: This activity complies with California Assembly Bill 1195, signed November 2005, requiring continuing medical education courses with patient care components to include curricula in the subject of cultural and linguistic competency. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area.

Location: ,

Credit Hours: